[Usefulness of macrolides as anti-inflammatories in respiratory diseases].
The macrolides are antibiotics that, besides their anti-bacterial action, have an anti-inflammatory effect, by decreasing the activity of the immune cells and bacteria cell changes. An increase the survival of patients suffering from diffuse panbronchiolitis was already seen in the 1980s, after being treated with erythromycin. Currently, the use of macrolides in various chronic inflammatory diseases has increased significantly. Clinical improvements associated to the administration of macrolides have been observed in diseases such as, cystic fibrosis, asthma, and bronchiectasis. However, despite the apparent clinical benefit they seem to provide, the published results up until now are controversial and conclusive results are unable to be obtained. This means that further clinical trials are necessary to confirm or refute the long-term use of these drugs, which are not free of adverse effects, mainly the appearance of resistant bacteria.
Sevilla-Sánchez
Daniel
D
Servicio de Farmacia, Hospital Clínic de Barcelona, Barcelona, España. danielsevillasanchez@gmail.com
Soy-Muner
Dolors
D
Soler-Porcar
Néstor
N
D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D018942:Macrolides / Q000494:pharmacology / Q000627:therapeutic use*; D012120:Respiration Disorders / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D018942:Macrolides